Precision Optics Inc Quick Ratio (POCI) starting from the fourth quarter 2026 to fourth quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Precision Optics Corporation Inc   (NASDAQ: POCI)

Precision Optics Inc 's Quick Ratio

POCI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Current Liabilities decreased faster than Precision Optics Inc 's Cash & cash equivalent, this led to improvement in Precision Optics Inc 's Quick Ratio to 1.11, above Precision Optics Corporation Inc average Quick Ratio.

Within Medical Equipment & Supplies industry 103 other companies have achieved higher Quick Ratio than Precision Optics Inc in fourth quarter 2026. While Quick Ratio total ranking in the fourth quarter 2026 has deteriorated compared to the prior quarter from 1659 to 1875.

Explain Quick Ratio?
How much Cash & cash equivalents POCI´s has?
What are POCI´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/POCI/financial-strength
https://api.csimarket.com/api/v1/companies/POCI/fundamentals
https://api.csimarket.com/api/v1/companies/POCI/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
POCI Quick Ratio (Jun 30 2026)
Q4
(Mar 31 2026)
Q3
(Dec 31 2025)
Q2
(Sep 30 2025)
Q1
(Jun 30 2025)
Q4
Y / Y Current Liabilities Change 43.51 %
Y / Y Cash & cash equivalent Change 454.83 %
Quick Ratio MRQ 1.11
POCI's Total Ranking # 1875
Seq. Current Liabilities Change -13.39 %
Seq. Cash & cash equivalent Change -7.85 %



Quick Ratio fourth quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 104
Healthcare Sector # 608
Overall Market # 1875


Quick Ratio Statistics
High Average Low
2.94 0.54 0.01
(Jun 30 2013)   (Dec 31 2012)




Financial Statements
Precision Optics Inc 's Current Liabilities $ 9 Millions Visit POCI's Balance sheet
Precision Optics Inc 's Cash & cash equivalent $ 10 Millions Visit POCI's Balance sheet
Source of POCI's Sales Visit POCI's Sales by Geography


Cumulative Precision Optics Inc 's Quick Ratio

POCI's Quick Ratio for the trailling 12 Months

POCI Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 59.71 %
Y / Y Cash & cash equivalent TTM Growth 340.94 %
Quick Ratio TTM 0.62
Total Ranking TTM # 4002
Seq. Current Liabilities TTM Growth 7.89 %
Seq. Cash & cash equivalent TTM Growth 54.78 %


On the trailing twelve months basis POCI Cash & cash equivalent more than doubled by 454.83 % in Q4 2026 year on year, faster than Current Liabilities, this led to increase in in Precision Optics Inc 's Quick Ratio to 0.62, above POCI average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 204 other companies have achieved higher Quick Ratio than Precision Optics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2026 from 2986 to 4002.

Explain Quick Ratio?
How much Cash & cash equivalents POCI´s has?
What are POCI´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 205
Healthcare Sector # 901
Within the Market # 4002


trailing twelve months Quick Ratio Statistics
High Average Low
1.85 0.45 0.1
(Jun 30 2013)   (Dec 31 2024)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Fractyl Health Inc   3.00 $ 47.140  Millions$ 15.736  Millions
Vivani Medical Inc   2.99 $ 19.894  Millions$ 6.659  Millions
Retractable Technologies Inc  2.98 $ 39.870  Millions$ 13.365  Millions
Neuropace Inc   2.97 $ 51.700  Millions$ 17.433  Millions
Apyx Medical Corp  2.95 $ 27.617  Millions$ 9.354  Millions
Omada Health Inc   2.94 $ 221.712  Millions$ 75.483  Millions
Clearpoint Neuro Inc   2.85 $ 29.363  Millions$ 10.313  Millions
Penumbra Inc  2.82 $ 658.795  Millions$ 233.776  Millions
Tactile Systems Technology Inc   2.81 $ 69.853  Millions$ 24.821  Millions
Glaukos Corp  2.80 $ 286.594  Millions$ 102.329  Millions
Pulmonx Corporation  2.76 $ 56.393  Millions$ 20.405  Millions
Intuitive Surgical Inc   2.71 $ 5,216.200  Millions$ 1,922.900  Millions
Neuraxis Inc   2.69 $ 8.342  Millions$ 3.096  Millions
Edwards Lifesciences Corporation  2.68 $ 4,291.700  Millions$ 1,604.100  Millions
Modular Medical Inc  2.63 $ 3.920  Millions$ 1.489  Millions
Co diagnostics Inc   2.55 $ 7.299  Millions$ 2.863  Millions
Staar Surgical Co  2.47 $ 181.489  Millions$ 73.394  Millions
Electromed Inc   2.35 $ 20.450  Millions$ 8.714  Millions
EBR Systems, Inc.  2.33 $ 113.533  Millions$ 48.662  Millions
Beta Bionics Inc   2.29 $ 44.318  Millions$ 19.355  Millions
Medinotec Inc   2.15 $ 2.519  Millions$ 1.171  Millions
Escalon Medical Corp   2.07 $ 3.065  Millions$ 1.481  Millions
Atricure Inc   2.05 $ 167.786  Millions$ 81.916  Millions
Inspire Medical Systems inc   1.79 $ 127.761  Millions$ 71.282  Millions
Tandem Diabetes Care Inc   1.79 $ 455.996  Millions$ 254.509  Millions
Warby Parker Inc   1.79 $ 292.674  Millions$ 163.480  Millions
Capsovision Inc   1.76 $ 9.077  Millions$ 5.158  Millions
Anika Therapeutics Inc   1.73 $ 38.412  Millions$ 22.147  Millions
Genedx Holdings Corp   1.71 $ 132.548  Millions$ 77.648  Millions
Merit Medical Systems Inc  1.70 $ 450.906  Millions$ 264.933  Millions

Date modified: 2026-10-10T06:36:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.